# | PDB (Resolution Å) |
Site # | Ligand | EC number | GO terms | UniProt | PubMed | Binding affinity |
---|---|---|---|---|---|---|---|---|
1 | 8jyl:A (2.33) | BS01 | VUL | N/A | N/A | Q00IB3 | N/A | |
2 | 8jyl:A (2.33) | BS02 | MG | N/A | N/A | Q00IB3 | N/A | |
3 | 8jyl:B (2.33) | BS01 | VUL | N/A | N/A | Q00IB3 | N/A | |
4 | 8jyl:B (2.33) | BS02 | MG | N/A | N/A | Q00IB3 | N/A | |
5 | 8jyl:C (2.33) | BS01 | VUL | N/A | N/A | Q00IB3 | N/A | |
6 | 8jyl:C (2.33) | BS02 | MG | N/A | N/A | Q00IB3 | N/A | |
7 | 8jyl:D (2.33) | BS01 | VUL | N/A | N/A | Q00IB3 | N/A | |
8 | 8jyl:D (2.33) | BS02 | MG | N/A | N/A | Q00IB3 | N/A | |
9 | 8jyl:E (2.33) | BS01 | VUL | N/A | N/A | Q00IB3 | N/A | |
10 | 8jyl:E (2.33) | BS02 | MG | N/A | N/A | Q00IB3 | N/A | |
11 | 8jyl:F (2.33) | BS01 | VUL | N/A | N/A | Q00IB3 | N/A | |
12 | 8jyl:F (2.33) | BS02 | MG | N/A | N/A | Q00IB3 | N/A |